Tharimmune (THAR) Earnings Date & Reports

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

THAR is expected to report earnings to fall 98.75% to -5 cents per share on November 29

Q3'23

Est.

$-0.05

Q2'23

Missed

by $3.84

Q1'23

Missed

by $5.52

The last earnings report on August 30 showed earnings per share of -400 cents, missing the estimate of -15 cents. With 1.79K shares outstanding, the current market capitalization sits at 2.47M.

View a ticker or compare two or three

Compare

THAR